SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TA, GMED, CBIO, AQUA

Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

NEW YORK, April 13, 2023

NEW YORK, April 13, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

TravelCenters of America Inc. (NASDAQ: TA)'s sale to BP p.l.c. for $86.00 per share in cash. If you are a TravelCenters shareholder, click here to learn more about your rights and options.

Globus Medical, Inc. (NYSE: GMED)'s merger with NuVasive, Inc. Under the terms of the merger agreement, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock. If you are a Globus shareholder, click here to learn more about your rights and options.

Catalyst Biosciences, Inc. (NASDAQ: CBIO)'s merger with GNI Group Ltd. If you are a Catalyst shareholder, click here to learn more about your rights and options.

Evoqua Water Technologies Corp. (NYSE: AQUA)'s sale to Xylem Inc. for 0.480 shares of Xylem for each Evoqua share. If you are an Evoqua shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

ARIVA.DE Börsen-Geflüster

Kurse

Evoqua Water Techn

0,00%

Globus Medical

47,20 €

0,00%

Gyre Therapeutics Inc

16,00 €

0,00%

TRAVELCENTERS AMERICA INC

0,00%

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-update-halper-sadeh-llc-investigates-ta-gmed-cbio-aqua-301797099.html

SOURCE Halper Sadeh LLP

Mehr Nachrichten zur Gyre Therapeutics Inc Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.